Data path: financials for HCLTECH are currently sourced via the US ADR cross-listing (NYSE/NASDAQ). The fair value and score on this page reflect the latest cached compute against that data path. A direct NSE data path is in active development; values will refresh once it lands. How our data sourcing works →
HCL Technologies Limited
HCLTECH · IT Services · NSE
₹1,146
Current Market Price
Fair Value (DCF)
₹1,623
Discount to FV
+41.5%
Updated 15m ago
YieldIQ Score
50/100
Piotroski F-Score
6/9
Economic Moat
None
Confidence
44%
ROE
22.1%
Debt/Equity
0.07
WACC
9.8%
Market Cap
₹3.10 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
34.0%
Return on capital employed
EV / EBITDA
11.2×
Enterprise multiple
Debt / EBITDA
0.2×
Leverage vs earnings
Interest Coverage
37.1×
EBIT covers interest
Current Ratio
2.22×
Short-term liquidity
Asset Turnover
1.14×
Revenue per ₹ of assets
Revenue CAGR (3Y)
-76.2%
3-year revenue growth
Revenue CAGR (5Y)
-55.5%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹1,146.3
Bear case
Discount -26.7%
Base case
Discount +29.4%
Bull case
Discount +38.9%
Ratio Trends
HCLTECH · last 9 annual periods
ROE
22.1%
ROCE
34.0%
Operating Margin
—
Debt / Equity
0.07×
PE
0.3×
EV / EBITDA
—
Historical Financials
HCLTECH · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹85.7K Cr | ₹101.5K Cr | ₹109.9K Cr | ₹117.1K Cr | ₹130.1K Cr | +11.0% |
| EBITDA | ₹21.6K Cr | ₹24.0K Cr | ₹25.7K Cr | ₹28.0K Cr | ₹27.3K Cr | +6.1% |
| EBIT | ₹17.3K Cr | ₹19.8K Cr | ₹21.5K Cr | — | — | +5.7% |
| PAT | ₹13.5K Cr | ₹14.9K Cr | ₹15.7K Cr | ₹17.4K Cr | ₹16.6K Cr | +5.3% |
| EPS (diluted) | ₹49.77 | ₹54.79 | ₹57.86 | — | — | +3.8% |
| CFO | ₹16.9K Cr | ₹18.0K Cr | ₹22.4K Cr | ₹22.3K Cr | ₹20.0K Cr | +4.3% |
| CapEx | — | ₹-1661 Cr | ₹-1048 Cr | ₹-1108 Cr | ₹-1422 Cr | — |
| FCF | — | ₹16.3K Cr | ₹21.4K Cr | ₹21.2K Cr | ₹18.6K Cr | +3.2% |
| Total Assets | ₹89.0K Cr | ₹93.4K Cr | ₹99.8K Cr | ₹105.5K Cr | ₹116.3K Cr | +6.9% |
| Total Debt | — | ₹4786 Cr | ₹5756 Cr | ₹6279 Cr | ₹5215 Cr | +2.2% |
| Shareholders' Equity | — | ₹65.4K Cr | ₹68.3K Cr | ₹69.7K Cr | ₹75.2K Cr | +3.5% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
HCLTECH vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
INFY Infosys | +56.3% | 40 | Below Fair Value | 31.4% | 18.4× |
WIPRO Wipro Limited | +329.2% | 40 | Data Limited | 14.9% | 0.3× |
TCS Tata Consultancy Services | +59.8% | 40 | Below Fair Value | 45.9% | 17.3× |
LTM LTM | — | — | Pending | 20.9% | — |
TECHM Tech Mahindra Limited | +298.2% | 40 | Data Limited | 16.2% | 0.4× |
Click a ticker to view its fair-value analysis.
Dividend History
40 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹264.00/sh
Last payout
2026-04-24
₹24.00
Peak payout
₹24.00
Trailing yield
5.23%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. HCL Technologies Limited (HCLTECH.NS) trades at 1146.30 vs a model fair value of 1622.52, a gap of 41.5%. Piotroski F-score: 6/9. Moat la...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of HCLTECH →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for HCLTECH →
Compare
Head-to-head with peers
Compare HCLTECH side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse HCLTECHNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.